The biology of mammary transgenes: five rules.

Research output: Contribution to journalReview article

34 Citations (Scopus)

Abstract

The development of hyperplasias, dysplasias, and mammary tumors has been studied extensively in transgenic mice. It is now becoming clear that transgenes activate and participate in oncogenic pathways that govern the events surrounding neoplastic progression in transgenic mice. The oncogenic pathways control mammary growth, development, and neoplastic progression. Some of the key features of transgenic biology can be expressed in the following rules: (1) Mammary development is related to the type and amount of transgene expressed; (2) dysplasias and tumors develop from secondary mutations; (3) the transgenes determine tumor phenotype; (4) transgenes may activate dominant oncogenic pathways; and (5) the oncogenic pathway determines prognosis. The study of the comparative pathology of mammary tumorigenesis in many strains of transgenic mice provides examples of these principles.

Original languageEnglish (US)
Pages (from-to)61-73
Number of pages13
JournalJournal of Mammary Gland Biology and Neoplasia
Volume1
Issue number1
DOIs
StatePublished - Jan 1 1996

Fingerprint

Transgenes
Breast
Transgenic Mice
Growth and Development
Hyperplasia
Neoplasms
Carcinogenesis
Pathology
Breast Neoplasms
Phenotype
Mutation

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

The biology of mammary transgenes : five rules. / Cardiff, Robert.

In: Journal of Mammary Gland Biology and Neoplasia, Vol. 1, No. 1, 01.01.1996, p. 61-73.

Research output: Contribution to journalReview article

@article{8ac0ab71ece44a58a451234d48d11dd8,
title = "The biology of mammary transgenes: five rules.",
abstract = "The development of hyperplasias, dysplasias, and mammary tumors has been studied extensively in transgenic mice. It is now becoming clear that transgenes activate and participate in oncogenic pathways that govern the events surrounding neoplastic progression in transgenic mice. The oncogenic pathways control mammary growth, development, and neoplastic progression. Some of the key features of transgenic biology can be expressed in the following rules: (1) Mammary development is related to the type and amount of transgene expressed; (2) dysplasias and tumors develop from secondary mutations; (3) the transgenes determine tumor phenotype; (4) transgenes may activate dominant oncogenic pathways; and (5) the oncogenic pathway determines prognosis. The study of the comparative pathology of mammary tumorigenesis in many strains of transgenic mice provides examples of these principles.",
author = "Robert Cardiff",
year = "1996",
month = "1",
day = "1",
doi = "10.1007/BF02096303",
language = "English (US)",
volume = "1",
pages = "61--73",
journal = "Journal of Mammary Gland Biology and Neoplasia",
issn = "1083-3021",
publisher = "Springer New York",
number = "1",

}

TY - JOUR

T1 - The biology of mammary transgenes

T2 - five rules.

AU - Cardiff, Robert

PY - 1996/1/1

Y1 - 1996/1/1

N2 - The development of hyperplasias, dysplasias, and mammary tumors has been studied extensively in transgenic mice. It is now becoming clear that transgenes activate and participate in oncogenic pathways that govern the events surrounding neoplastic progression in transgenic mice. The oncogenic pathways control mammary growth, development, and neoplastic progression. Some of the key features of transgenic biology can be expressed in the following rules: (1) Mammary development is related to the type and amount of transgene expressed; (2) dysplasias and tumors develop from secondary mutations; (3) the transgenes determine tumor phenotype; (4) transgenes may activate dominant oncogenic pathways; and (5) the oncogenic pathway determines prognosis. The study of the comparative pathology of mammary tumorigenesis in many strains of transgenic mice provides examples of these principles.

AB - The development of hyperplasias, dysplasias, and mammary tumors has been studied extensively in transgenic mice. It is now becoming clear that transgenes activate and participate in oncogenic pathways that govern the events surrounding neoplastic progression in transgenic mice. The oncogenic pathways control mammary growth, development, and neoplastic progression. Some of the key features of transgenic biology can be expressed in the following rules: (1) Mammary development is related to the type and amount of transgene expressed; (2) dysplasias and tumors develop from secondary mutations; (3) the transgenes determine tumor phenotype; (4) transgenes may activate dominant oncogenic pathways; and (5) the oncogenic pathway determines prognosis. The study of the comparative pathology of mammary tumorigenesis in many strains of transgenic mice provides examples of these principles.

UR - http://www.scopus.com/inward/record.url?scp=0029677188&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029677188&partnerID=8YFLogxK

U2 - 10.1007/BF02096303

DO - 10.1007/BF02096303

M3 - Review article

C2 - 10887481

AN - SCOPUS:0029677188

VL - 1

SP - 61

EP - 73

JO - Journal of Mammary Gland Biology and Neoplasia

JF - Journal of Mammary Gland Biology and Neoplasia

SN - 1083-3021

IS - 1

ER -